295 related articles for article (PubMed ID: 24317117)
1. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome.
Clement LC; Macé C; Avila-Casado C; Joles JA; Kersten S; Chugh SS
Nat Med; 2014 Jan; 20(1):37-46. PubMed ID: 24317117
[TBL] [Abstract][Full Text] [Related]
2. Dual role of circulating angiopoietin-like 4 (ANGPTL4) in promoting hypertriglyceridemia and lowering proteinuria in nephrotic syndrome.
Vaziri ND; Moradi H
Am J Kidney Dis; 2014 Oct; 64(4):495-8. PubMed ID: 24838183
[No Abstract] [Full Text] [Related]
3. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome.
Clement LC; Avila-Casado C; Macé C; Soria E; Bakker WW; Kersten S; Chugh SS
Nat Med; 2011 Jan; 17(1):117-22. PubMed ID: 21151138
[TBL] [Abstract][Full Text] [Related]
4. Nephrotic syndrome: Negative feedback loop reveals novel potential therapy.
Kirk R
Nat Rev Nephrol; 2014 Feb; 10(2):63. PubMed ID: 24342959
[No Abstract] [Full Text] [Related]
5. Growth hormone upregulates ANGPTL4 mRNA and suppresses lipoprotein lipase via fatty acids: Randomized experiments in human individuals.
Hjelholt AJ; Søndergaard E; Pedersen SB; Møller N; Jessen N; Jørgensen JOL
Metabolism; 2020 Apr; 105():154188. PubMed ID: 32084431
[TBL] [Abstract][Full Text] [Related]
6. The proteinuria-hypertriglyceridemia connection as a basis for novel therapeutics for nephrotic syndrome.
Clement LC; Macé C; Del Nogal Avila M; Marshall CB; Chugh SS
Transl Res; 2015 Apr; 165(4):499-504. PubMed ID: 25005737
[TBL] [Abstract][Full Text] [Related]
7. Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoid-regulated triglyceride metabolism.
Koliwad SK; Kuo T; Shipp LE; Gray NE; Backhed F; So AY; Farese RV; Wang JC
J Biol Chem; 2009 Sep; 284(38):25593-601. PubMed ID: 19628874
[TBL] [Abstract][Full Text] [Related]
8. [Role of Angptl4 in nephrotic syndrome: a two-faced protein].
Macé C; Clément LC
Med Sci (Paris); 2014; 30(6-7):605-7. PubMed ID: 25014443
[No Abstract] [Full Text] [Related]
9. Angiopoietin-like-4 and minimal change disease.
Cara-Fuentes G; Segarra A; Silva-Sanchez C; Wang H; Lanaspa MA; Johnson RJ; Garin EH
PLoS One; 2017; 12(4):e0176198. PubMed ID: 28441404
[TBL] [Abstract][Full Text] [Related]
10. Angiopoietin-Like Protein 4 and Postprandial Skeletal Muscle Lipid Metabolism in Overweight and Obese Prediabetics.
van der Kolk BW; Goossens GH; Jocken JW; Kersten S; Blaak EE
J Clin Endocrinol Metab; 2016 Jun; 101(6):2332-9. PubMed ID: 27011113
[TBL] [Abstract][Full Text] [Related]
11. Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease.
Chugh SS; Macé C; Clement LC; Del Nogal Avila M; Marshall CB
Front Pharmacol; 2014; 5():23. PubMed ID: 24611049
[TBL] [Abstract][Full Text] [Related]
12. Regulation of angiopoietin-like 4 and lipoprotein lipase in human adipose tissue.
Dijk W; Schutte S; Aarts EO; Janssen IMC; Afman L; Kersten S
J Clin Lipidol; 2018; 12(3):773-783. PubMed ID: 29555209
[TBL] [Abstract][Full Text] [Related]
13. Angiopoietin-like 4 Modifies the Interactions between Lipoprotein Lipase and Its Endothelial Cell Transporter GPIHBP1.
Chi X; Shetty SK; Shows HW; Hjelmaas AJ; Malcolm EK; Davies BS
J Biol Chem; 2015 May; 290(19):11865-77. PubMed ID: 25809481
[TBL] [Abstract][Full Text] [Related]
14. Fasting induces ANGPTL4 and reduces LPL activity in human adipose tissue.
Ruppert PMM; Michielsen CCJR; Hazebroek EJ; Pirayesh A; Olivecrona G; Afman LA; Kersten S
Mol Metab; 2020 Oct; 40():101033. PubMed ID: 32504883
[TBL] [Abstract][Full Text] [Related]
15. Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids.
Kersten S; Lichtenstein L; Steenbergen E; Mudde K; Hendriks HF; Hesselink MK; Schrauwen P; Müller M
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):969-74. PubMed ID: 19342599
[TBL] [Abstract][Full Text] [Related]
16. The C-terminal fibrinogen-like domain of angiopoietin-like 4 stimulates adipose tissue lipolysis and promotes energy expenditure.
McQueen AE; Kanamaluru D; Yan K; Gray NE; Wu L; Li ML; Chang A; Hasan A; Stifler D; Koliwad SK; Wang JC
J Biol Chem; 2017 Sep; 292(39):16122-16134. PubMed ID: 28842503
[TBL] [Abstract][Full Text] [Related]
17. Effects of hyperinsulinemia on lipoprotein lipase, angiopoietin-like protein 4, and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 in subjects with and without type 2 diabetes mellitus.
Ruge T; Sukonina V; Kroupa O; Makoveichuk E; Lundgren M; Svensson MK; Olivecrona G; Eriksson JW
Metabolism; 2012 May; 61(5):652-60. PubMed ID: 22078753
[TBL] [Abstract][Full Text] [Related]
18. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids.
Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Zhen EY; Regmi A; Roell WC; Guo H; Luo MJ; Gimeno RE; Van't Hooft F; Konrad RJ
J Lipid Res; 2020 Aug; 61(8):1203-1220. PubMed ID: 32487544
[TBL] [Abstract][Full Text] [Related]
19. The acute phase response stimulates the expression of angiopoietin like protein 4.
Lu B; Moser A; Shigenaga JK; Grunfeld C; Feingold KR
Biochem Biophys Res Commun; 2010 Jan; 391(4):1737-41. PubMed ID: 20043872
[TBL] [Abstract][Full Text] [Related]
20. RNA Interference Targeting Liver Angiopoietin-Like Protein 3 Protects from Nephrotic Syndrome in a Rat Model Via Amelioration of Pathologic Hypertriglyceridemia.
Zhao Y; Goto M; Vaziri ND; Khazaeli M; Liu H; Farahanchi N; Khanifar E; Farzaneh T; Haslett PA; Moradi H; Soundarapandian MM
J Pharmacol Exp Ther; 2021 Mar; 376(3):428-435. PubMed ID: 33443084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
